0

Journal Articles

in Cardiac Biomarkers
 1-20 of 189 Articles
JAMA Internal Medicine | 
Original Investigation |  May 13, 2013
High-Sensitivity Cardiac Troponin T Levels and Secondary Events in Outpatients With Coronary Heart Disease From the Heart and Soul Study
Alexis L. Beatty, MD; Ivy A. Ku, MD, MAS; Robert H. Christenson, PhD; et al.
JAMA Intern Med. 2013;173(9):763-769. doi:10.1001/jamainternmed.2013.116.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Editor's Correspondence |  May 13, 2013
Routine Noninvasive Testing and Highly Sensitive Troponin Immunoassays
Giuseppe Lippi, MD; Gianfranco Cervellin, MD
JAMA Intern Med. 2013;173(9):834-835. doi:10.1001/jamainternmed.2013.3773.
JAMA Internal Medicine | 
Editor's Correspondence |  May 13, 2013
Routine Noninvasive Testing and Highly Sensitive Troponin Immunoassays—Reply
Vinay Prasad, MD; Michael Cheung, MD; Adam Cifu, MD
JAMA Intern Med. 2013;173(9):834-835. doi:10.1001/jamainternmed.2013.4089.
JAMA Internal Medicine | 
Original Investigation |  April 22, 2013
Bias in Associations of Emerging Biomarkers With Cardiovascular Disease
Ioanna Tzoulaki, PhD; Konstantinos C. Siontis, MD; Evangelos Evangelou, PhD; et al.
JAMA Intern Med. 2013;173(8):664-671. doi:10.1001/jamainternmed.2013.3018.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Invited Commentary |  April 22, 2013
Biomarkers in Cardiovascular Medicine:  The Shame of Publication Bias
Comment on “Bias in Associations of Emerging Biomarkers With Cardiovascular Disease”
Steven E. Nissen, MD
JAMA Intern Med. 2013;173(8):671-672. doi:10.1001/jamainternmed.2013.4074.
JAMA Pediatrics | 
Article |  April 01, 2013
Effect of Volunteering on Risk Factors for Cardiovascular Disease in Adolescents:  A Randomized Controlled Trial
Hannah M. C. Schreier, PhD; Kimberly A. Schonert-Reichl, PhD; Edith Chen, PhD
JAMA Pediatr. 2013;167(4):327-332. doi:10.1001/jamapediatrics.2013.1100.
INCLUDES: , Supplemental Content
JAMA Ophthalmology | 
Epidemiology |  April 01, 2013
C-Reactive Protein and the Incidence of Macular Degeneration: Pooled Analysis of 5 Cohorts
Vinod P. Mitta, MD, MPH; William G. Christen, ScD; Robert J. Glynn, PhD; et al.
JAMA Ophthalmol. 2013;131(4):507-513. doi:10.1001/jamaophthalmol.2013.2303.
JAMA Internal Medicine | 
Editor's Correspondence |  March 25, 2013
High-Five for High-Sensitivity Cardiac Troponin T: Depends on the Precision and Analytical Platform
Peter A. Kavsak, PhD
JAMA Intern Med. 2013;173(6):477. doi:10.1001/jamainternmed.2013.2270.
JAMA Internal Medicine | 
Editor's Correspondence |  March 25, 2013
Testing Times: We Are Still Some Way From Getting the Best Out of Sensitive Troponin Assays
Edward Watts Carlton, MBChB, MCEM; James Hugo Phillimore Gamble, MA, Cantab, BMBCh, MRCP; Kim Greaves, BSc, MD, FACC, FRCP
JAMA Intern Med. 2013;173(6):477-478. doi:10.1001/jamainternmed.2013.2273.
JAMA Internal Medicine | 
Editor's Correspondence |  March 25, 2013
Testing Times: We Are Still Some Way From Getting the Best Out of Sensitive Troponin Assays—Reply
Tobias Reichlin, MD; Christian Mueller, MD, FESC
JAMA Intern Med. 2013;173(6):477-478. doi:10.1001/jamainternmed.2013.2787.
JAMA Internal Medicine | 
Challenges in Clinical Electrocardiography |  March 11, 2013 ONLINE FIRST
Finding Needles in a Haystack—Discussion
JAMA Intern Med. 2013;():2-3. doi:10.1001/jamainternmed.2013.128b.
JAMA Surgery | 
Original Article |  February 01, 2013
Soluble CD40 Ligand in Morbidly Obese Patients:  Effect of Body Mass Index on Recovery to Normal Levels After Gastric Bypass Surgery
Juan A. Baena-Fustegueras, MD; Eva Pardina, PhD; Eva Balada, MD; et al.
JAMA Surg. 2013;148(2):151-156. doi:10.1001/jamasurgery.2013.419.
JAMA Psychiatry | 
Original Article |  February 01, 2013
Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals
Marie Kim Wium-Andersen, MD; David Dynnes Ørsted, MD; Sune Fallgaard Nielsen, MScEE, PhD; et al.
JAMA Psychiatry. 2013;70(2):176-184. doi:10.1001/2013.jamapsychiatry.102.
INCLUDES: , Supplemental Content
JAMA Surgery | 
From the JAMA Network |  January 01, 2013
Role of Fourth-Generation Troponin in Predicting Mortality in Noncardiac Surgery
Christopher L. Wolfgang, MD, PhD
JAMA Surg. 2013;148(1):12-13. doi:10.1001/jamasurg.2013.607.
JAMA Psychiatry | 
Original Article |  January 01, 2013
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression:  The Role of Baseline Inflammatory Biomarkers
Charles L. Raison, MD; Robin E. Rutherford, MD; Bobbi J. Woolwine, MSW; et al.
JAMA Psychiatry. 2013;70(1):31-41. doi:10.1001/2013.jamapsychiatry.4.
INCLUDES: , Supplemental Content
JAMA Pediatrics | 
Commentary |  December 01, 2012
Changing the Conversation Regarding Pediatric Cholesterol Screening:  The Rare Disease Paradigm
Matthew W. Gillman, MD, SM
Arch Pediatr Adolesc Med. 2012;166(12):1097-1098. doi:10.1001/archpediatrics.2012.1907.
JAMA Internal Medicine | 
Research Letters |  October 22, 2012
Within-Person Variability in High-Sensitivity C-Reactive Protein
Julie K. Bower, PhD, MPH; Mariana Lazo, MD, PhD, ScM; Stephen P. Juraschek, BA; et al.
Arch Intern Med. 2012;172(19):1519-1521. doi:10.1001/archinternmed.2012.3712.
INCLUDES: , Supplemental Content
JAMA | 
Medical News and Perspectives |  October 17, 2012
New Definition of Myocardial Infarction Puts Biomarkers Front and Center
Mike Mitka, MSJ
JAMA. 2012;308(15):1511-1512. doi:10.1001/jama.2012.12794.
JAMA Internal Medicine | 
Invited Commentary |  September 10, 2012
Myocardial Infarction Rule-out in the Emergency Department: Are High-Sensitivity Troponins the Answer?:  Comment on “One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T”
L. Kristin Newby, MD, MHS
Arch Intern Med. 2012;172(16):1218-1219. doi:10.1001/archinternmed.2012.1808.
JAMA Internal Medicine | 
Original Investigation |  September 10, 2012
One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T
Tobias Reichlin, MD; Christian Schindler, PhD; Beatrice Drexler, MD; et al.
Arch Intern Med. 2012;172(16):1211-1218. doi:10.1001/archinternmed.2012.3698.
INCLUDES: CME , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Routine Noninvasive Testing and Highly Sensitive Troponin Immunoassays
Giuseppe Lippi, MD; Gianfranco Cervellin, MD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Routine Noninvasive Testing and Highly Sensitive Troponin Immunoassays—Reply
Vinay Prasad, MD; Michael Cheung, MD; Adam Cifu, MD
JAMA Internal Medicine
Original Investigation  |  April 8, 2013
High-Sensitivity Cardiac Troponin T Levels and Secondary Events in Outpatients With Coronary Heart Disease From the Heart and Soul Study
Alexis L. Beatty, MD; Ivy A. Ku, MD, MAS; Robert H. Christenson, PhD; et al.
JAMA Internal Medicine
Original Investigation  |  March 25, 2013
Bias in Associations of Emerging Biomarkers With Cardiovascular Disease
Ioanna Tzoulaki, PhD; Konstantinos C. Siontis, MD; Evangelos Evangelou, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems